{
    "medicine_id": "f4d74681a15de2fa7645dd85a4877b42e58acd8f",
    "platform_id": "DB05077",
    "metadata": {
        "name": "Arcapta Neohaler 75 ug 1 Capsule",
        "composition": "75 ug 1 SLV319",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in obesity",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00907",
                        "description": "Cocaine may increase the tachycardic activities of SLV319"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trospium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Disopyramide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Ipratropium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Metixene is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Terfenadine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trihexyphenidyl is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Procyclidine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Profenamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine bromide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Darifenacin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tridihexethyl is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Anisotropine methylbromide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Atropine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Nicardipine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Pirenzepine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzquinamide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Propantheline is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methantheline is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Cycrimine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tolterodine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Flavoxate is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Diphenidol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tiotropium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Phenglutarimide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mazaticol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Etybenzatropine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Otilonium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Poldine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Bevonium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Rociverine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Bornaprine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Etanautine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Midodrine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Phenmetrazine"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Bucindolol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Epanolol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tryptophan"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Baclofen"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethchlorvynol"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Succinylcholine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eletriptan"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Enflurane"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Temazepam"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butabarbital"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methysergide"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ropinirole"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Atomoxetine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etomidate"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Talbutal"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tolcapone"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cetirizine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trimethadione"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Doxylamine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Meprobamate"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Palonosetron"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carisoprodol"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alprazolam"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dexbrompheniramine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metocurine iodide"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methocarbamol"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Triprolidine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metharbital"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dronabinol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlordiazepoxide"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Adinazolam"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hydroxyzine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cisatracurium"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mazindol"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lisuride"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Linezolid"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Furazolidone"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dyclonine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trazodone"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metaxalone"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trimethobenzamide"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Atracurium besylate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Risperidone"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Meclizine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Riluzole"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clidinium"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phensuximide"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Progabide"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Azelastine"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levocabastine"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with MMDA"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rufinamide"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Perampanel"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sodium oxybate"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of Tachycardia can be increased when Nicotine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of Tachycardia can be increased when Bethanidine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of Tachycardia can be increased when Isoetharine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of Tachycardia can be increased when Guanabenz is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of Tachycardia can be increased when Adenosine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of Tachycardia can be increased when Bitolterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of Tachycardia can be increased when Salmeterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of Tachycardia can be increased when Formoterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of Tachycardia can be increased when Salbutamol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of Tachycardia can be increased when Arbutamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of Tachycardia can be increased when Cilostazol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of Tachycardia can be increased when Arformoterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of Tachycardia can be increased when Pirbuterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of Tachycardia can be increased when Ephedra sinica root is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of Tachycardia can be increased when Bambuterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of Tachycardia can be increased when Phendimetrazine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Rimonabant"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of Tachycardia can be increased when Solriamfetol is combined with SLV319"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}